Becker CE, Cone JE, Gerberding J (1989). Occupational infection with human immunodeficiency virus (HIV). Risks and risk reduction. Ann. Intern. Med. 110(8):653-656.
Crossref

Chacko J, Isaac R (2007). Percutaneous injuries among medical interns and their knowledge and practice of post-exposure prophylaxis for HIV. Indian J. Public Health 51(2):127-129.

Date HL, Fisher M (2007). HIV infection. In: Walker R, Whittlesea C (eds.), Clinical pharmacy and therapeutics. New York: Churchill Livingstone Elsevier. pp. 568-569.

Department of Health (DH) (2004). HIV Post-Exposure Prophylaxis: Guidance from the UK Chief Medical Officer's Expert Advisory Group on AIDS.

Erhabor O, Ejele OA, Nwauche CA (2007). Epidemiology and Management of Occupational Exposure to Blood-borne Viral Infections in a Resource-poor Setting: the case for Availability of Post-exposure Prophylaxis. Niger. J. Clin. Pract. 10(2):100-104.

Federal Ministry of Health (FMOH) (2010). National Guidelines for HIV and AIDS Treatment and Care in Adolescents and Adults.

Fisher M, Benn P, Evans B, Pozniak A, Jones M, MacLean S, Davidson O, Summerside J, Hawkins D (2006). UK Guideline for the use of PEP for HIV Following Sexual Exposure. Int. J. STD AIDS 17:81-92.
Crossref

Gold J, Tomkins M (2005). Occupational Post-exposure Prophylaxis for HIV: a Discussion Paper; For the Technical Meeting for the Development of Guidelines and Policies on Occupational and Non-Occupational Post Exposure Prophylaxis (PEP), Convened by World Health Organization/International Labour Organization Geneva.

Khan JO, Martin JN, Roland ME, Bamberger JD, Chesney M, Chambers D, Franses K, Coates TJ, Katz MH (2001). Feasibility of Post-exposure Prophylaxis (PEP) against Human Immunodeficiency Virus Infection after Sexual or Injection Drug Use Exposure: the San Francisco PEP Study. J. Infect. Dis. 183:707-714.
Crossref

Onyedum CC, Chukwuka C, Iyoke CA, Omotola OF (2011). HIV Post Exposure Prophylaxis (PEP) services in a Nigerian Health institution. J. Int. Assoc. Physicians AIDS 10(3):171-175.
Crossref

Pinkerton SD, Martin JN, Roland ME, Katz MH, Coates TJ, Kahn JO (2004). Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States. AIDS 18:15.
Crossref

Tebeje B, Hailu C (2010). Assessment of HIV Post-Exposure Prophylaxis Use among Health Workers of Governmental Health Institutions in Jimma Zone, Oromiya Region, Southwest Ethiopia. Ethiop. J. Health Sci. 20:1.

The US President's Emergency Plan for AIDS Relief PEPFAR (2009). Planning and Reporting: Next Generation Indicators Reference Guide (Version 1.1).

Varghese GM, Abraham OC, Mathai D (2003). Post-exposure prophylaxis for blood borne viral infections in healthcare workers. Postgrad. Med. J. 79:324-328.
Crossref

World Health Organization (WHO) (2007). Post-exposure Prophylaxis to Prevent HIV Infection: Joint WHO/ILO Guidelines on Post-exposure Prophylaxis (PEP) to Prevent HIV Infection.

Young T, Arens FJ, Kennedy GE, Laurie JW, Rutherford GW (2007). Antiretroviral Post-exposure Prophylaxis (PEP) for Occupational HIV Exposure. Cochrane Database of Systematic Reviews Issue 1, Art. No.:CD002835.
Crossref